查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970180

2026-2034年全球子宮肌瘤治療器械市場規模、佔有率、趨勢和成長分析報告

Global Uterine Fibroid Treatment Device Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計子宮肌瘤治療設備的市場規模將從 2025 年的 81.5 億美元成長到 2034 年的 190.2 億美元，並預計從 2026 年到 2034 年將以 9.87% 的複合年成長率成長。

隨著微創療法和先進介入技術的普及，子宮肌瘤治療器械市場預計將持續成長。未來的器材將利用人工智慧輔助影像診斷、即時導航和機器人引導等技術，提高手術精準度、病患安全性和復原效果。與電子健康記錄和遠端監測的整合將最佳化治療方案的發展和後續護理。

新興技術包括先進的栓塞系統（可在最大限度減少創傷的同時提高療效）、聚焦超音波設備和能量消融工具。結合預測分析技術，可實現個人化治療方案的選擇，從而最佳化患者療效和資源利用。小巧、便攜且符合人體工學設計的設備使其能夠在門診和診所環境中得到更廣泛的應用。

未來成長將得益於公眾意識的提高、子宮肌瘤盛行率的上升以及微創治療方法的廣泛應用。透過結合精準儀器、人工智慧輔助規劃和以患者為中心的照護模式，子宮肌瘤治療方案將改善治療效果、提升營運效率並提高醫療服務的可近性。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球子宮肌瘤治療器材市場：依技術分類

  • 市場分析、洞察與預測
  • 手術治療方法
  • 腹腔鏡手術技術
  • 消融技術
  • 栓塞術

第5章：全球子宮肌瘤治療器械市場：依治療方法分類

  • 市場分析、洞察與預測
  • 侵入性治療
  • 微創治療
  • 非侵入性治療

第6章 全球子宮肌瘤治療器械市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Insightec
    • CooperSurgical Inc
    • Hologic Inc
    • Lumenis Be Ltd
    • Conmed Corporation
    • Gynesonics
    • Merit Medical Systems
簡介目錄
Product Code: VMR11213083

The Uterine Fibroid Treatment Device Market size is expected to reach USD 19.02 Billion in 2034 from USD 8.15 Billion (2025) growing at a CAGR of 9.87% during 2026-2034.

The uterine fibroid treatment device market is poised for growth as minimally invasive therapies and advanced interventional technologies gain adoption. Future devices will leverage AI-assisted imaging, real-time navigation, and robotic guidance to improve procedural accuracy, patient safety, and recovery outcomes. Integration with electronic medical records and remote monitoring will optimize treatment planning and follow-up care.

Emerging technologies include advanced embolization systems, focused ultrasound devices, and energy-based ablation tools that minimize invasiveness while enhancing efficacy. Integration with predictive analytics will guide personalized treatment selection, optimizing patient outcomes and resource utilization. Compact, portable, and ergonomically designed devices will enable broader access in outpatient and clinic settings.

Future growth will be driven by rising awareness, increasing prevalence of uterine fibroids, and adoption of minimally invasive treatment options. By combining precision devices, AI-assisted planning, and patient-centric care models, uterine fibroid treatment solutions will enhance procedural outcomes, operational efficiency, and healthcare accessibility.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Surgical Techniques
  • Laparoscopic Techniques
  • Ablation Techniques
  • Embolization Techniques

By Mode of Treatment

  • Invasive Treatment
  • Minimally Invasive Treatment
  • Non-invasive Treatment

COMPANIES PROFILED

  • Medtronic, Stryker, Boston Scientific Corporation, Insightec, CooperSurgical Inc, Hologic Inc, Lumenis Be Ltd, Conmed Corporation, Gynesonics, Merit Medical Systems
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET: BY TECHNOLOGY 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Surgical Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Laparoscopic Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.4. Ablation Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.5. Embolization Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET: BY MODE OF TREATMENT 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Mode Of Treatment
  • 5.2. Invasive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Minimally Invasive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.4. Non-invasive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET: BY REGION 2022-2034(USD MN and K Units)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.2.1 By Technology
    • 6.2.2 By Mode Of Treatment
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.3.1 By Technology
    • 6.3.2 By Mode Of Treatment
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.4.1 By Technology
    • 6.4.2 By Mode Of Treatment
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.5.1 By Technology
    • 6.5.2 By Mode Of Treatment
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.6.1 By Technology
    • 6.6.2 By Mode Of Treatment
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL UTERINE FIBROID TREATMENT DEVICE INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic
    • 8.2.2 Stryker
    • 8.2.3 Boston Scientific Corporation
    • 8.2.4 Insightec
    • 8.2.5 CooperSurgical Inc
    • 8.2.6 Hologic Inc
    • 8.2.7 Lumenis Be Ltd
    • 8.2.8 Conmed Corporation
    • 8.2.9 Gynesonics
    • 8.2.10 Merit Medical Systems